| [1] |
European Association of Urology. EAU Guidelines on Non-muscle-invasive (TaT1, CIS) Bladder Cancer[EB/OL]. (2023)[2025-03-20].
URL
|
| [2] |
European Association of Urology. EAU guidelines on muscle-invasive and metastatic cancer[EB/OL]. (2023)[2025-03-20].
URL
|
| [3] |
|
| [4] |
Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data[J]. Radiology, 2016, 278(2):563-577. DOI: 10.1148/radiol.2015151169.
|
| [5] |
LeCun Y, Bengio Y, Hinton G. Deep learning[J]. Nature. 2015, 521(7553):436-444. DOI: 10.1038/nature14539.
|
| [6] |
Zhang G, Wu Z, Zhang X, et al. CT-based radiomics to predict muscle invasion in bladder cancer[J]. Eur Radiol, 2022, 32(5): 3260-3268. DOI: 10.1007/s00330-021-08426-3.
|
| [7] |
Zhang G, Wu Z, Xu L, et al. Deep learning on enhanced CT images can predict the muscular invasiveness of bladder cancer[J]. Front Oncol, 2021, 11: 654685. DOI: 10.3389/fonc.2021.654685.
|
| [8] |
Panebianco V, Narumi Y, Altun E, et al. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (vesical imaging-reporting and data system)[J]. Eur Urol, 2018, 74(3): 294-306. DOI: 10.1016/j.eururo.2018.04.029.
|
| [9] |
Woo S, Panebianco V, Narumi Y, et al. Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis[J]. Eur Urol Oncol, 2020, 3(3): 306-315. DOI: 10.1016/j.euo.2020.02.007.
|
| [10] |
Li J, Cao K, Lin H, et al. Predicting muscle invasion in bladder cancer by deep learning analysis of MRI: comparison with vesical imaging-reporting and data system[J]. Eur Radiol, 2023, 33(4): 2699-2709. DOI: 10.1007/s00330-022-09272-7.
|
| [11] |
Zheng Z, Xu F, Gu Z, et al. Combining multiparametric MRI radiomics signature with the vesical imaging-reporting and data system (VI-RADS) score to preoperatively differentiate muscle invasion of bladder cancer[J]. Front Oncol, 2021, 11: 619893. DOI: 10.3389/fonc.2021.619893.
|
| [12] |
Şam Özdemir M, Azamat S, Özdemir H, et al. Preoperative prediction of muscle invasiveness in bladder cancer: the role of 3D volumetric radiomics using diffusion-weighted MRI, the VI-RADS score, or a combination of both[J]. Ann Surg Oncol, 2024, 31(9): 5845-5850. DOI: 10.1245/s10434-024-15760-5.
|
| [13] |
Xu X, Zhang X, Tian Q, et al. Quantitative identification of nonmuscle-invasive and muscle-invasive bladder carcinomas: a multiparametric MRI radiomics analysis[J]. J Magn Reson Imaging, 2019, 49(5): 1489-1498. DOI: 10.1002/jmri.26327.
|
| [14] |
Huang J, Chen G, Liu H, et al. MRI-based automated machine learning model for preoperative identification of variant histology in muscle-invasive bladder carcinoma[J]. Eur Radiol, 2024, 34(3): 1804-1815. DOI: 10.1007/s00330-023-10137-w.
|
| [15] |
Li L, Zhang J, Zhe X, et al. Prediction of histopathologic grades of bladder cancer with radiomics based on MRI: Comparison with traditional MRI[J]. Urol Oncol, 2024, 42(6): 176.e9-176.e20. DOI: 10.1016/j.urolonc.2024.02.008.
|
| [16] |
Song H, Yang S, Yu B, et al. CT-based deep learning radiomics nomogram for the prediction of pathological grade in bladder cancer: a multicenter study[J]. Cancer Imaging, 2023, 23(1): 89. DOI: 10.1186/s40644-023-00609-z.
|
| [17] |
Gao RZ, Wen R, Wen DY, et al. Radiomics analysis based on ultrasound images to distinguish the tumor stage and pathological grade of bladder cancer[J]. J Ultrasound Med, 2021, 40(12): 2685-2697. DOI: 10.1002/jum.15659.
|
| [18] |
Wei Z, Bai X, Xv Y, et al. A radiomics-based interpretable machine learning model to predict the HER2 status in bladder cancer: a multicenter study[J]. Insights Imaging, 2024, 15(1): 262. DOI: 10.1186/s13244-024-01840-3.
|
| [19] |
Han X, Guan J, Guo L, et al. A CT-based interpretable deep learning signature for predicting PD-L1 expression in bladder cancer: a two-center study[J]. Cancer Imaging, 2025, 25(1): 27. DOI: 10.1186/s40644-025-00849-1.
|
| [20] |
Sun R, Zhang M, Yang L, et al. Preoperative CT-based deep learning radiomics model to predict lymph node metastasis and patient prognosis in bladder cancer: a two-center study[J]. Insights Imaging, 2024, 15(1): 21. DOI: 10.1186/s13244-023-01569-5.
|
| [21] |
Gresser E, Woźnicki P, Messmer K, et al. Radiomics signature using manual versus automated segmentation for lymph node staging of bladder cancer[J]. Eur Urol Focus, 2023, 9(1): 145-153. DOI: 10.1016/j.euf.2022.08.015.
|
| [22] |
Girard A, Dercle L, Vila-Reyes H, et al. A machine-learning-based combination of criteria to detect bladder cancer lymph node metastasis on [18F] FDG PET/CT: a pathology-controlled study[J]. Eur Radiol, 2023, 33(4): 2821-2829. DOI: 10.1007/s00330-022-09270-9.
|
| [23] |
Ye L, Chen Y, Xu H, et al. Radiomics of contrast-enhanced computed tomography: a potential biomarker for pretreatment prediction of the response to Bacillus calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer[J]. Front Cell Dev Biol, 2022, 10: 814388. DOI: 10.3389/fcell.2022.814388.
|
| [24] |
Zhang X, Wang Y, Zhang J, et al. Development of a MRI-based radiomics nomogram for prediction of response of patients with muscle-invasive bladder cancer to neoadjuvant chemotherapy[J]. Front Oncol, 2022, 12: 878499. DOI: 10.3389/fonc.2022.878499.
|
| [25] |
Wei Z, Xv Y, Liu H, et al. A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study[J]. Int J Surg, 2024, 110(5): 2922-2932. DOI: 10.1097/JS9.0000000000001194.
|
| [26] |
Wang H, Zhang M, Miao J, et al. Deep learning signature based on multiphase enhanced CT for bladder cancer recurrence prediction: a multi-center study[J]. EClinicalMedicine, 2023, 66: 102352. DOI: 10.1016/j.eclinm.2023.102352.
|
| [27] |
Ronneberger O, Fischer P, Brox T. U-Net: convolutional networks for biomedical image segmentation[C]//Medical Image Computing and Computer-Assisted Intervention-MICCAI 2015. Cham: Springer, 2015: 234-241. DOI: 10.1007/978-3-319-24574-4_28.
|
| [28] |
Lee MC, Wang SY, Pan CT, et al. Development of deep learning with RDA U-Net network for bladder cancer segmentation[J]. Cancers, 2023, 15(4): 1343. DOI: 10.3390/cancers15041343.
|
| [29] |
Yu J, Cai L, Chen C, et al. Cascade Path Augmentation Unet for bladder cancer segmentation in MRI[J]. Med Phys, 2022, 49(7): 4622-4631. DOI: 10.1002/mp.15646.
|
| [30] |
Ye Y, Luo Z, Qiu Z, et al. Radiomics prediction of muscle invasion in bladder cancer using semi-automatic lesion segmentation of MRI compared with manual segmentation[J]. Bioengineering (Basel), 2023, 10(12): 1355. DOI: 10.3390/bioengineering10121355.
|
| [31] |
Kidoh M, Shinoda K, Kitajima M, et al. Deep learning based noise reduction for brain MR imaging: tests on phantoms and healthy volunteers[J]. Magn Reson Med Sci, 2020, 19(3): 195-206. DOI: 10.2463/mrms.mp.2019-0018.
|
| [32] |
Taguchi S, Tambo M, Watanabe M, et al. Prospective validation of vesical imaging-reporting and data system using a next-generation magnetic resonance imaging scanner-is denoising deep learning reconstruction useful?[J]. J Urol, 2021, 205(3): 686-692. DOI: 10.1097/JU.0000000000001373.
|
| [33] |
Watanabe M, Taguchi S, Machida H, et al. Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field[J]. Eur Radiol, 2022, 32(11): 7513-7521. DOI: 10.1007/s00330-022-08813-4.
|
| [34] |
Chen X, Sun S, Bai N, et al. A deep learning-based auto-segmentation system for organs-at-risk on whole-body computed tomography images for radiation therapy[J]. Radiother Oncol, 2021, 160: 175-184. DOI: 10.1016/j.radonc.2021.04.019.
|
| [35] |
Gong W, Yao Y, Ni J, et al. Deep learning-based low-dose CT for adaptive radiotherapy of abdominal and pelvic tumors[J]. Front Oncol, 2022, 12: 968537. DOI: 10.3389/fonc.2022.968537.
|
| [36] |
Qureshi TA, Chen X, Xie Y, et al. MRI/RNA-seq-based radiogenomics and artificial intelligence for more accurate staging of muscle-invasive bladder cancer[J]. Int J Mol Sci, 2023, 25(1): 88. DOI: 10.3390/ijms25010088.
|
| [37] |
Zheng Z, Guo Y, Huang X, et al. CD8A as a prognostic and immunotherapy predictive biomarker can be evaluated by MRI radiomics features in bladder cancer[J]. Cancers, 2022, 14(19): 4866. DOI: 10.3390/cancers14194866.
|
| [38] |
Chan EO, Pradere B, Teoh JY, et al. The use of artificial intelligence for the diagnosis of bladder cancer: a review and perspectives[J]. Curr Opin Urol, 2021, 31(4): 397-403. DOI: 10.1097/MOU.0000000000000900.
|
| [39] |
Khoraminia F, Fuster S, Kanwal N, et al. Artificial intelligence in digital pathology for bladder cancer: hype or hope? a systematic review[J]. Cancers, 2023, 15(18): 4518. DOI: 10.3390/cancers15184518.
|
| [40] |
Bazarkin A, Morozov A, Androsov A, et al. Assessment of prostate and bladder cancer genomic biomarkers using artificial intelligence: a systematic review[J]. Curr Urol Rep, 2024, 25(1): 19-35. DOI: 10.1007/s11934-023-01193-2.
|
| [41] |
Wu S, Chen X, Pan J, et al. An artificial intelligence system for the detection of bladder cancer via cystoscopy: a multicenter diagnostic study[J]. J Natl Cancer Inst, 2022, 114(2): 220-227. DOI: 10.1093/jnci/djab179.
|
| [42] |
Subramanya SK, Li R, Wang Y, et al. Deep learning for histopathological segmentation of smooth muscle in the urinary bladder[J]. BMC Med Inform Decis Mak, 2023, 23(1): 122. DOI: 10.1186/s12911-023-02222-3.
|
| [43] |
Chen S, Jiang L, Zheng X, et al. Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer[J]. Cancer Sci, 2021, 112(7): 2905-2914. DOI: 10.1111/cas.14927.
|
| [44] |
Meng XY, Zhou XH, Li S, et al. Machine learning-based detection of bladder cancer by urine cfDNA fragmentation hotspots that capture cancer-associated molecular features[J]. Clin Chem, 2024, 70(12): 1463-1473. DOI: 10.1093/clinchem/hvae156.
|